Provided by Tiger Trade Technology Pte. Ltd.

Pliant Therapeutics, Inc.

1.17
-0.0600-4.88%
Post-market: 1.16-0.0085-0.73%18:36 EDT
Volume:726.68K
Turnover:863.64K
Market Cap:72.44M
PE:-0.48
High:1.26
Open:1.24
Low:1.15
Close:1.23
52wk High:1.95
52wk Low:1.09
Shares:61.91M
Float Shares:55.57M
Volume Ratio:1.79
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4336
EPS(LYR):-2.4336
ROE:-61.55%
ROA:-30.15%
PB:0.40
PE(LYR):-0.48

Loading ...

Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 14, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report
Jun 17, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 27, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]